RANBAXY LABORATORIES LTD. - Announces Q4 results and Limited Review Report for the Quarter ended December 31, 2013

Ranbaxy Laboratories Ltd has announced the following results for the quarter ended December 31, 2013:<br/><br/>The Unaudited Standalone results for the Quarter ended December 31, 2013<br/><br/>The Company has posted a net loss of Rs. (3959.60) million for the quarter ended December 31, 2013 as compared to net loss of Rs.(6160.96) million for the quarter ended December 31, 2012. Total Income has decreased from Rs. 15086.32 million for the quarter ended December 31, 2012 to Rs. 13871.62 million for the quarter ended December 31, 2013.<br/><br/>The Consolidated Results are as follows:<br/><br/>The Unaudited Consolidated results for the Quarter ended December 31, 2013<br/><br/>The Group has posted a net loss after taxes, Minority Interest and Share of Profit of Associates of Rs. (1589.44) million for the quarter ended December 31, 2013 as compared to net loss of Rs. (4924.48) million for the quarter ended December 31, 2012. Total Income has increased from Rs. 27878.87 million for the quarter ended December 31, 2012 to Rs. 29292.30 million for the quarter ended December 31, 2013.<br/><br/>"The figures for the Quarter ended December 31, 2012 are Audited".